Last Updated on April 24, 2024 by The Health Master
Raw Material
Thane, Maharashtra – In a concerning incident, Thane Police have registered a case against unidentified individuals for allegedly tampering with a valuable consignment of pharmaceutical raw material.
The pilfered substance, Gliclazide IP powder, was estimated to be worth over Rs 36 lakh, raising serious concerns about supply chain security and potential health risks.
Modus Operandi of the Tampering
Targeted Material:
The complaint details the theft of Gliclazide IP powder, a crucial component in the manufacturing of diabetes medications.
Tampering Method:
As per the investigation, the accused strategically replaced the original Gliclazide IP powder with a similar-looking substance during transit or storage.
This deceptive tactic makes detection during initial inspection difficult.
Possible Points of Tampering:
The authorities suspect the tampering occurred at two critical stages:
- During transportation – The consignment was being transported from Nhava Sheva port in Navi Mumbai to a pharmaceutical godown located in Rahnal, Bhiwandi.
- During storage – Alternatively, the pilfering might have happened while the raw material was stored at the godown itself.
Investigation Underway
FIR Registered:
Based on the complaint filed by a 62-year-old businessman from Virar, Palghar district (the importer of the material from China), the police have registered an FIR under sections 406 (criminal breach of trust) and 407 (criminal breach of trust by carrier) of the Indian Penal Code (IPC).
Suspects in Focus:
The investigation is currently focused on identifying the culprits. The prime suspects include:
- The driver employed by the transportation agency responsible for delivering the consignment.
- Individuals with access to the godown where the raw material was temporarily stored.
Timeline of Events:
The tampering is believed to have transpired sometime between September and November 2023.
Current Status:
No arrests have been made yet. The investigation is ongoing to apprehend the perpetrators and recover the stolen Gliclazide IP powder (if possible).
Potential Implications
This incident highlights the vulnerability of pharmaceutical supply chains to tampering and counterfeiting.
The use of a substitute substance in place of the original Gliclazide IP powder raises concerns about the:
Efficacy of Medications:
Altered drug compositions can significantly impact the effectiveness of medicines, potentially jeopardizing patient health.
Safety of Consumers:
Unknown substitutes might introduce harmful ingredients, leading to severe health complications.
Authorities are actively investigating the case to ensure the safety and integrity of the pharmaceutical supply chain.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
CDSCO releases draft Guidelines for Clinical Trial in India
DCC Approves Ban on Harmful Antibiotics in Food Products
DCC: Sub-committee to look into one-time NOC for exports
CDSCO: New draft Guidelines for Pharmaceutical Distribution in India
Codeine Phosphate and its Regulations in India
USFDA approval granted for Fluoxetine Tablets
Belarus Seeks 84 Medicines: A Lucrative Opportunity for Indian Pharma
New Regulations for Competent Persons in Charge of Homoeopathy Wholesalers
Hyderabad Gears Up for 73rd IPC to be held from July 5 to 7, 2024
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
